Medtronic Inc (MDT)

MDT (NYSE:Health Services)
$65.19
pos +0.00
+0.00%
Today's Range: 64.93 - 65.79 | MDT Avg Daily Volume: 9,505,600
Last Update: 09/12/14 - 4:00 PM EDT
Volume: 0
YTD Performance: 13.59%
Open: $0.00
Previous Close: $65.74
52 Week Range: $52.44 - $66.21
Oustanding Shares: 979,516,413
Market Cap: 64,393,408,991
6-Month Chart
TheStreet Ratings Grade for MDT
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 9 10 7
Moderate Buy 2 2 2 0
Hold 6 5 5 11
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.79 1.72 1.68 2.22
Latest Dividend: 0.30
Latest Dividend Yield: 1.86%
Dividend Ex-Date: 10/01/14
Price Earnings Ratio: 22.21
Price Earnings Comparisons:
MDT Sector Avg. S&P 500
22.21 22.30 28.96
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
7.24% 21.67% 94.13%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.50 0.07 0.02
Net Income -11.60 -0.01 0.00
EPS -10.40 0.07 0.02
Earnings for MDT:
EBITDA 5.86B
Revenue 17.01B
Average Earnings Estimates
Qtr (10/14) Qtr (01/15) FY (04/15) FY (04/16)
Average Estimate $0.96 $0.98 $4.05 $4.35
Number of Analysts 11 11 13 11
High Estimate $0.97 $1.00 $4.07 $4.47
Low Estimate $0.96 $0.97 $4.02 $4.17
Prior Year $0.91 $0.91 $3.82 $4.05
Growth Rate (Year over Year) 5.79% 7.79% 5.92% 7.44%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Update
Sep 11, 2014 | 8:00 AM EDT
MDT was initiated with a Neutral rating, Sterne Agee said. $68 price target. Company lacks near-term catalysts. 
Sadly, these five themes have driven folks away from the market's remarkable five-year run.
Update
Aug 21, 2014 | 6:58 AM EDT
MDT - Medtronic Inc Annual Shareholders Meeting - 11:30AM

This Morning's Market Setup Real Money Pro($)

Where it began.
A wave of M&A in the health sector makes sense.
Update
Jun 20, 2014 | 8:52 AM EDT
MDT was upgraded to Buy from Hold, Jefferies said. Covidien acquisition gives freer acces to cash to investors. Price target increased ...
It isn't based on complacency; it's based on the facts.
Update
Jun 18, 2014 | 7:29 AM EDT
MDT was upgraded to Overweight from Equal Weight, Barclays said. Driven by potential benefits from acquisition of COV. $73 price target...
Bullish
Jun 17, 2014 | 8:11 AM EDT
MDT was upgraded from Neutral to Outperform, Credit Suisse said. $70 price target. Covidien purchase should add to earnings. 
Bullish
Jun 17, 2014 | 8:07 AM EDT
MDT was upgraded from Neutral to Buy, BTIG said. $73 price target. Covidien is a premium asset and a good use of the company's cash.&nb...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.